Tobacco Online According to Tobacco News, the U.S. Food and Drug Administration said it is setting up a nicotine steering committee to help formulate and implement nicotine policies and regulations. It is reported that the implementation of the policy is designed to support the agency announced in July a comprehensive new tobacco regulatory program, the FDA called "the country's public health crisis of tobacco addiction."
The committee includes top leaders from the Tobacco Products Center (CTP), Center for Drug Evaluation and Research, and commissioners' offices to study nicotine replacement therapy (NRTs) that help people quit smoking. The CTP states in a press release: "The committee will review the evolving science that underpins NRT assessment, including the type of safety and effectiveness studies required by the FDA and how to use and label these products." The committee's first The move is to hold public hearings and get public feedback on NRT products and their public health, scientific, regulatory and legal considerations for quitting smoking. "
The hearing is scheduled for January 26 at the White Oak campus in Silver Spring, Maryland. The request to attend the hearing must be completed by January 2. However, electronic or written comments will be submitted by February 15 after the public hearing.